Innovative Eyewear (LUCY) CTO trades grants and sales in 2026
Rhea-AI Filing Summary
Innovative Eyewear Inc (LUCY) reported that Chief Technology Officer David Eric Cohen had a mix of stock grants and sales. On April 2 and August 19, 2026, he received 18,200 shares of common stock each time as grant/award acquisitions at $0.00 per share. Across April 2, April 9, July 6, and August 19, 2026, he sold a total of 15,769 shares of common stock in open-market or private transactions at per-share prices ranging from $1.0436–$1.17 and a weighted average price of $0.6802 for the August 19 sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,631 shares
Net Buy
6 txns
Insider
Cohen David Eric
Role
Chief Technology Officer
Sold
15,769 shs ($15K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 18,200 | $0.00 | $0.00 |
| Sale | Common Stock F1 | 6,136 | $0.6802 | $4K |
| Sale | Common Stock | 1,860 | $1.17 | $2K |
| Sale | Common Stock | 1,860 | $1.1111 | $2K |
| Grant/Award | Common Stock | 18,200 | $0.00 | $0.00 |
| Sale | Common Stock | 5,913 | $1.0436 | $6K |
Holdings After Transaction:
Common Stock — 27,342 shares (Direct)
Footnotes (1)
- F1. The price reported in Column 4 is an average price of $0.6802. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Key Figures
Grant on April 2, 2026: 18,200 shares of Common Stock at $0.0000 per share
Grant on August 19, 2026: 18,200 shares of Common Stock at $0.0000 per share
Total shares sold: 15,769 shares of Common Stock
+5 more
8 metrics
Grant on April 2, 2026
18,200 shares of Common Stock at $0.0000 per share
Reported as a grant, award, or other acquisition
Grant on August 19, 2026
18,200 shares of Common Stock at $0.0000 per share
Reported as a grant, award, or other acquisition
Total shares sold
15,769 shares of Common Stock
Four sale transactions between April 2 and August 19, 2026
Sale on April 2, 2026
5,913 shares at $1.0436 per share
Sale in open market or private transaction
Sale on April 9, 2026
1,860 shares at $1.1111 per share
Sale in open market or private transaction
Sale on July 6, 2026
1,860 shares at $1.1700 per share
Sale in open market or private transaction
Sale on August 19, 2026
6,136 shares at weighted average price of $0.6802 per share
Sale in open market or private transaction with footnoted weighted average price
Net buy/sell shares
-15,769
Form-level transaction summary netBuySellShares
Key Terms
Grant, award, or other acquisition, Sale in open market or private transaction, weighted average price, Rule 10b5-1, +1 more
5 terms
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Sale in open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
weighted average price financial
"The price reported in Column 4 is an average price of $0.6802."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transactions did LUCY’s CTO David Eric Cohen report on this Form 4?
He reported two stock grants of 18,200 shares each on April 2 and August 19, 2026, and four sales totaling 15,769 shares between April 2 and August 19, 2026, all in Innovative Eyewear Inc common stock.
What stock grants did LUCY’s CTO receive according to this filing?
He received 18,200 shares of Innovative Eyewear Inc common stock on April 2, 2026 and another 18,200 shares on August 19, 2026, both reported as grant, award, or other acquisition transactions at $0.00 per share.
Were LUCY insider trades made under a Rule 10b5-1 trading plan?
The document-level checkbox indicating trades under a Rule 10b5-1 plan is not checked, so these transactions are not affirmed as being made pursuant to such a trading plan in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.